IAM is universally acknowledged as the world’s leading IP business information provider. IAM was launched in July 2003 to address the need for organizations to maximize the value of their intellectual property and other intangibles, and to examine the strategies that they can put in place to do this. IAM is unique because it treats intellectual property as a business asset and tool, rather than simply as a legal right. With this unequalled appeal to the boardroom, IAM has firmly established itself as the only IP publication that many senior corporate executives read regularly.
Click here for further information on other IAM events.
Summary
With disruptive political and legislative change on the horizon at home and abroad, it has never been more important for European biopharma patent professionals to have a crystal-clear understanding of the changes shaping IP protection and value creation.
IAM’s third annual Pharma & Biotech IP event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.
Attendees will:
Registrations / general enquiries
Customer Services
Pharma@GlobeBMG.com
T +44 20 7939 4011
Additional ticket sales
Matthew Bridgewater
mbridgewater@GlobeBMG.com
T +44 20 7939 4263
Sponsorship enquiries
John Eborall
jeborall@GlobeBMG.com
T +44 20 7940 6862
Speaking opportunities
Aaron Rawcliffe
arawcliffe@GlobeBMG.com
T +44 20 7939 4262
Media partnership opportunities
Jennifer Tabailloux
jtabailloux@GlobeBMG.com
T +44 20 7939 4258
If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock